Abstract
Metachromatic leukodystrophy is an autosomal recessive neurodegenerative disorder of the myelin metabolism due to the impaired function of the lysosomal enzyme arylsulfatase A. Three major clinical variants of metachromatic leukodystrophy (MLD) have been described: late infantile, juvenile, and late onset. The infantile form, whose clinical onset is usually before the age of 2 years, is the most frequent. The juvenile form manifests itself between 3 and 16 years and the late-onset form manifests at any time after puberty. As of today, more than 150 mutations causing MLD have been identified in the ARSA gene that encodes arylsulfatase A. In this paper, we report our experience with the diagnosis of MLD in seven Italian patients from unrelated families. We found 11 different mutations, four of which have not been previously described: c.1215_1223del9 (p.406_408del), c.601 T>C (p.Tyr201His), c.655 T>A (p.Phe219Ile), and c.87C>A (p.Asp29Glu). Our data show once more that there are still several mutations to be discovered in the ARSA gene and there are rarely repeating ones found in the population. The predictive value of the enzyme activity tests in regard to clinical manifestations is extremely limited.
Similar content being viewed by others
References
Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249
Ashkenazy H, Erez E, Martz E, Pupko T, Ben-Tal N (2010) ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res 38 (Web Server issue): W529-33
Barth ML, Fensom A, Harris A (1995) Identification of seven novel mutations associated with metachromatic leukodystrophy. Hum Mutat 6(2):170–176
Bellesia G, Shea JE (2009) What determines the structure and stability of KFFE monomers, dimers, and protofibrils? Biophys J 96(3):875–886
Biffi A, Cesani M, Fumagalli F et al (2008) Metachromatic leukodystrophy - mutation analysis provides further evidence of genotype-phenotype correlation. Clin Genet 74(4):349–357
Capriotti E, Fariselli P, Casadio R (2005) I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res 33(Web Server issue): W306-10
Dierks T, Lecca MR, Schlotterhose P, Schmidt B, von Figura K (1999) Sequence determinants directing conversion of cysteine to formylglycine in eukaryotic sulfatases. EMBO J 18(8):2084–2091
Fiser A, Simon I, Barton GJ (1996) Conservation of amino acids in multiple alignments: aspartic acid has unexpected conservation. FEBS Lett 397(2–3):225–229
Gieselmann V, Polten A, Kreysing J, von Figura K (1989) Arylsulfatase A pseudodeficiency: loss of a N-glycosylation site and a polyadenylation signal. Proc Nat Acad Sci USA 86:9436–9440
Gilis D, Rooman M (2000) PoPMuSiC, an algorithm for predicting protein mutant stability changes: application to prion proteins. Protein Eng 13(12):849–856
Grossi S, Regis S, Rosano C et al (2008) Molecular analysis of ARSA and PSAP genes in twenty-one Italian patients with metachromatic leukodystrophy: identification and functional characterization of 11 novel ARSA alleles. Hum Mutat 29(11):E220–E230
Hermann S, Schestag F, Polten A et al (2000) Characterization of four arylsulfatase A missense mutations G86D, Y201C, D255H, and E312D causing metachromatic leukodystrophy. Am J Med Genet 6:91(1): 68–73
Huang LT, Gromiha MM, Ho SY (2007) iPTREE-STAB: interpretable decision tree based method for predicting protein stability changes upon mutations. Bioinformatics 23(10):1292–1293
Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4(7):1073–1081
Kwasigroch JM, Gilis D, Dehouck Y, Rooman M (2002) PoPMuSiC, rationally designing point mutations in protein structures. Bioinformatics 18:1701–1702
Landau M, Mayrose I, Rosenberg Y et al (2005) ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res 33 (Web Server issue): W299-302
Lukatela G, Krauss N, Theis K et al (1998) Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis. Biochemistry 37(11):3654–3664
Marcão A, Azevedo JE, Gieselmann V, Sá Miranda MC (2003) Oligomerization capacity of two arylsulfatase A mutants: C300F and P425T. Biochem Biophys Res Commun 306(1):293–297
Marcão AM, Wiest R, Schindler K et al (2005) Adult onset metachromatic leukodystrophy without electroclinical peripheral nervous system involvement: a new mutation in the ARSA gene. Arch Neurol 62(2):309–313
Meyer EA, Castellano RK, Diederich F (2003) Interactions with aromatic rings in chemical and biological recognition. Angew Chem Int Ed Engl 42:1210–1250
Ng PC, Henikoff S (2002) Accounting for human polymorphisms predicted to affect protein function. Genome Res 12(3):436–446
Poeppel P, Abouzied MM, Völker C, Gieselmann V (2010) Misfolded endoplasmic reticulum retained subunits cause degradation of wild-type subunits of arylsulfatase A heteromers. FEBS J 277(16):3404–3414
Poeppel P, Habetha M, Marcão A, Büssow H, Berna L, Gieselmann V (2005) Missense mutations as a cause of metachromatic leukodystrophy. Degradation of arylsulfatase A in the endoplasmic reticulum. FEBS J 272(5):1179–1188
Polten A, Fluharty AL, Fluharty CB, Kappler J, von Figura K, Gieselmann V (1991) Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med 324(1):18–22
Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30(17):3894–3900
Regis S, Corsolini F, Stroppiano M, Cusano R, Filocamo M (2002) Contribution of arylsulfatase A mutations located on the same allele to enzyme activity reduction and metachromatic leukodystrophy severity. Hum Genet 110(4):351–355
Regis S, Corsolini F, Ricci V, Di Duca M, Filocamo M (2004) An unusual arylsulfatase A pseudodeficiency allele carrying a splice site mutation in a metachromatic leukodystrophy patient. Eur J Hum Genet 12(2):150–154
Schenk M, Koppisetty CA, Santos DC et al (2009) Interaction of arylsulfatase-A (ASA) with its natural sulfoglycolipid substrates: a computational and site-directed mutagenesis study. Glycoconj J 26(8):1029–1045
Schmidt B, Selmer T, Ingendoh A, von Figura K (1995) A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency. Cell 28;82(2):271–278
Stein C, Gieselmann V, Kreysing J et al (1989) Cloning and expression of human arylsulfatase A. J Biol Chem 264:1252–1259
Vagedes P, Saenger W, Knapp EW (2002) Driving forces of protein association: the dimer-octamer equilibrium in arylsulfatase A. Biophys J 83(6):3066–3078
von Bülow R, Schmidt B, Dierks T, von Figura K, Usón I (2001) Crystal structure of an enzyme-substrate complex provides insight into the interaction between human arylsulfatase A and its substrates during catalysis. J Mol Biol 305(2):269–277
von Figura K, Gieselmann V, Jaeken J (2001) Metachromatic leukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3695–3724
von Figura K, Schmidt B, Selmer T, Dierks T (1998) A novel protein modification generating an aldehyde group in sulfatases: its role in catalysis and disease. Bioessays 20(6):505–510
Waldow A, Schmidt B, Dierks T, von Bülow R, von Figura K (1999) Amino acid residues forming the active site of arylsulfatase A. Role in catalytic activity and substrate binding. J Biol Chem 274(18):12284–12288
Wu C, Lei H, Duan Y (2005) The role of Phe in the formation of well-ordered oligomers of amyloidogenic hexapeptide (NFGAIL) observed in molecular dynamics simulations with explicit solvent. Biophys J 88(4):2897–2906
Acknowledgments
The authors thank the patients with their families and their medical doctors.
Conflict of interest
The authors declare that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Galla, D., de Gemmis, P., Anesi, L. et al. An Italian Cohort Study Identifies Four New Pathologic Mutations in the ARSA Gene. J Mol Neurosci 50, 284–290 (2013). https://doi.org/10.1007/s12031-013-0006-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-013-0006-8